Physician
Watoto Pediatric & Adolescent Specialty, LLC
Watoto Pediatric & Adolescent Specialty, LLC was paid $798K by Medicaid between Jan 2018 and Dec 2024, across 38 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 31% of everything it billed.
33Billing provider infoWATOTO PEDIATRIC & ADOLESCENT SPECIALTY, LLC
GAINESVILLE, VA 20155
GAINESVILLE, VA 20155
33aNPI1457585481assigned 05/05/2009
33bProvider typePediatrics Physician
28Total paid$798K
24GClaims27,494
24DCodes billed38
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Virginia
Rank by total paid#128 of 817
Median peer was paid$29K
This provider vs. median27×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 3,483 | $78K | |
| 2019 | 4,600 | $99K | |
| 2020 | 3,675 | $83K | |
| 2021 | 5,076 | $128K | |
| 2022 | 4,684 | $170K | |
| 2023 | 3,211 | $124K | |
| 2024incomplete | 2,765 | $115K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 31% | 2,954 | 2,632 | $248K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 30% | 4,089 | 3,586 | $240K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 8.5% | 894 | 881 | $68K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 6.9% | 481 | 448 | $55K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 6.0% | 708 | 620 | $48K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 4.3% | 461 | 446 | $34K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 2.4% | 190 | 161 | $19K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.8% | 1,062 | 999 | $14K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.5% | 275 | 246 | $12K |
| 86408 | 1.4% | 387 | 347 | $11K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 1.3% | 126 | 126 | $11K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 678 | 607 | $7K |
26 more codes
| 90686 | <1% | 446 | $5K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 197 | $5K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 5,110 | $4K |
| 90670 | <1% | 153 | $2K | |
| 90461 | <1% | 6,298 | $2K | |
| 90698 | <1% | 147 | $2K | |
| 99173 | <1% | 762 | $2K | |
| 0072A | <1% | 34 | $1K | |
| 0071A | <1% | 31 | $1K | |
| 99383 | <1% | 13 | $1K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 83 | $1K |
| 90710 | <1% | 30 | $1K | |
| 90651 | <1% | 39 | $920.37 | |
| 90633 | <1% | 67 | $774.55 | |
| 90696 | <1% | 27 | $422.67 | |
| 90685 | <1% | 31 | $313.93 | |
| 87807 | <1% | 21 | $275.10 | |
| 90680 | <1% | 25 | $274.24 | |
| 99188 | <1% | 12 | $249.48 | |
| 99072 | <1% | 1,320 | $132.42 | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 17 | $106.21 |
| 99051 | <1% | 31 | $78.25 | |
| A7015 | Aerosol mask, used with dme nebulizer | <1% | 82 | $43.70 |
| 94761 | <1% | 82 | $7.60 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 82 | $4.86 |
| 91307 | <1% | 49 | $0.32 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialWILLIAMS, IRVING (PHYSICIAN/OWNER)